Mustafa APARCI, Ejder KARDEŞOĞLU, Bekir Sıtkı CEBECİ

Birinci basamak sağlık hizmeti düzeyinde kardiyovasküler hastalıklara yaklaşım

Özet: Ülkemizde birinci basamak sağlık hizmetlerinin önemi zamanla anlaşılmış ve gereken önem verilmeye başlanmıştır. Kardiyovasküler hastalıkların ve buna bağlı ölümlerin yaygınlaşması ilişkili hastalıkların erken tespit, uygun tedavi ve düzenli kontrollerini gerekli kılmaktadır. Günümüzde birinci basamak sağlık hizmetinde çalışan hekimlere bu nedenle büyük görevler düşmektedir. Bu yazıda da amacımız aterosklerotik kalp hastalıkları, hipertansiyon, diyabet ve ani kardiyak ölüm gibi kalp hastalıklarının sıkça kullanılan tanı metodu ve araçları ile güncel kılavuzların ışığında tedavi seçenekleri ve hedefleri hakkında kısa bilgiler vermektir.

Anahtar Kelimeler:

Kalp damar hastalıkları, Konu ile ilgili kılavuzlar, Birinci basamak sağlık hizmetleri, Tanı teknikleri, kalp damar

Approach to cardiovascular disease in primary care medicine

Abstract: Significance of primary health services was understood by the time and a distinct care began to be directed at in our country. Increasing prevalence of cardiovascular disease and death urged the health systems to provide early diagnosis, appropriate treatment and regular control of those patients. Thus primary health care physicians deserve currently greater importance. The purpose of this review is to mention shortly about the widely used diagnosis method and techniques and also treatment modalities and goals of atherosclerotic heart disease, hypertension, diabetes and sudden cardiac death in the direction of recent guidelines.

Keywords:

Cardiovascular Diseases, Guidelines as Topic, Primary Health Care, Diagnostic Techniques, Cardiovascular,

PDF

___

1. Approach to the cardiac patients. Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M, eds. İn The Merck Manual, 18th edition, Merck Research Laboratories, Whitehouse Station, NJ, pp572-584.
2. Wiviott SD, Braunwald E. Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction: Part I. Initial Evaluation and Management, and Hospital Care. Am Fam Physician 2004;70: 525- 32
3. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G,Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C. ACC/AH
4. A/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006;48: e247- e346.
5. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TN, Pepine CJ, Schaeffer JW, Smith EE, Steward DE, Théroux P: ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-STsegment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina) J Am Coll Cardiol; 40: 1366.2002
6. Smith SC. Secondary Prevention Overview. In: Cannon, CP, O’Gara, PT. Critical Pathways in Cardiovascular Medicine 2nd Ed. Lippincott Williams & Wilkins
7. Smith SC, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation 2006;113: 2364- 2365
8. Samaha FF, Rader DJ. Hyperlipidemia. In: Cannon, CP, O’Gara, PT. Critical Pathways in Cardiovascular Medicine 2nd Ed. Lippincott Williams & Wilkins
9. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28 (7): 1769-1778
10. The Seventh Report of the Joint Comité on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289: 2560-2572
11. Szmuilowicz ED, Pendergrass M. Diabetes and Metabolic Syndrome In: Cannon, CP, O’Gara, PT. Critical Pathways in Cardiovascular Medicine 2nd Ed. Lippincott Williams & Wilkins
12. American College of Endocrinology consensus statement on guidelines for glycemic control. Endocr Pract 2002;8 (Suppl 1): 5-11
13. Priori SG, Aliot E, Bloomstrom-Lundqvist C, Bossaert L et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology European Heart Journal (2001) 22, 1374-1450
14. Maron BJ. Hypertrophic Cardiomyopathy. Circulation. 2002;106: 2419
15. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in Sudden Cardiovascular Death in Young Competitive Athletes After Implementation of a Preparticipation Screening Program JAMA. 2006;296: 1593-1601
16. Williams RG, Chen AY. Identifying Athletes at Risk for Sudden Death JACC, 2003: 42,11,1964-6
17. Corrado D, Pelliccia A, Bjornstad HH et al Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol European Heart Journal (2005) 26, 516- 524 MacKenzie R. Short PR interval J. Insur. Med 2005;37 (2): 145-52 .